Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PCC and Fibrinogen vs FFP in Postpartum Haemorrhage
NCT01910675Phase 4Withdrawn
- Sponsor
- Helsinki University Hospital
- Start
- Jul 2013
- Primary completion
- Oct 2018
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 4 trial of coagulation factor X human in postpartum hemorrhage (PPH), sponsored by Helsinki University Hospital. Planned start Jul 2013; status: withdrawn.
02
Drugs
coagulation factor X human
03
Conditions
postpartum hemorrhage (PPH)
Beyond the preview
Go deeper on NCT01910675.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01910675.